Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
01/2008
01/01/2008US7314636 Biodegradable injectable implants containing glycolic acid
01/01/2008US7314633 Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
01/01/2008US7314624 Emulsion comprising an aqueous phase, an oil phase, and a solvent and an immunogen
12/2007
12/30/2007CA2592727A1 Nanoparticulate and controlled release compositions comprising a cephalosporin
12/27/2007WO2007150063A2 Compositions for lowering blood serum cholesterol and use in foods, beverages, and health supplements
12/27/2007WO2007150047A1 Encapsulated labile compound compositions and methods of making the same
12/27/2007WO2007150018A2 Steroid-containing sustained release intraocular implants and related methods
12/27/2007WO2007149902A1 Anti-inflammatory dissolvable film
12/27/2007WO2007149868A2 Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
12/27/2007WO2007149864A2 Non-hormonal vaginal contraceptive
12/27/2007WO2007149860A1 Segmented pharmaceutical dosage forms
12/27/2007WO2007149852A2 Modified factor viii and factor ix genes and vectors for gene therapy
12/27/2007WO2007149802A2 Formulation for delivery of immune response modifiers
12/27/2007WO2007149801A2 Enteric coated particles containing an active ingredient
12/27/2007WO2007149773A2 Punctal plugs for the delivery of active agents
12/27/2007WO2007149771A2 Punctal plugs for the delivery of active agents
12/27/2007WO2007149438A2 Pharmaceutical compositions
12/27/2007WO2007149119A1 Water stabilized aerosol formulation system and method of making
12/27/2007WO2007149010A1 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance
12/27/2007WO2007148806A1 Methods of using a thiazole derivative
12/27/2007WO2007148798A1 Reduced coenzyme q10-containing composition and method for producing the same
12/27/2007WO2007148786A1 Stabilized solid preparation
12/27/2007WO2007148772A1 Sugar-coated reparation of macrolide antibiotic
12/27/2007WO2007148752A1 Infusion preparation for dialysis patient
12/27/2007WO2007148744A1 Prophylactic or therapeutic agent for corneal/conjunctival disorder comprising fumaric acid derivative as active ingredient
12/27/2007WO2007148714A1 Implant using rifamycin derivative
12/27/2007WO2007148238A1 Electronic capsule for treating gastrointestinal disease
12/27/2007WO2007148116A2 Topical pharmaceutical formulations
12/27/2007WO2007147976A1 Effervescent granules or granular material
12/27/2007WO2007147902A2 Rehydratable pharmaceutical product
12/27/2007WO2007147882A2 Aqueous suspensions of tmc278
12/27/2007WO2007147873A1 Oral pharmaceutical composition of a poorly water-soluble active substance
12/27/2007WO2007147861A2 Sustained release formulations of aromatase inhibitors
12/27/2007WO2007147596A1 Galenical formulations of aliskiren and hydrochlorothiazide
12/27/2007WO2007147514A1 Tablets comprising candesartan cilexetil
12/27/2007WO2007147372A2 Pharmaceutical composition for administration by injection
12/27/2007WO2007147371A2 Pharmaceutical composition for oral administration
12/27/2007WO2007147319A1 Yin-nourishing capsule
12/27/2007WO2007147226A1 Effervescent formulation
12/27/2007WO2007127958A3 Detection and imaging of target tissue
12/27/2007WO2007127844A3 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye
12/27/2007WO2007127216A3 Osmotic drug delivery system comprising release enhancing agent
12/27/2007WO2007122635A3 Controlled release formulation comprising anti-epileptic drugs
12/27/2007WO2007122624A3 Non-covalent complexes of bioactive agents with starch for oral delivery
12/27/2007WO2007117110A3 Sustained-release pellets containing tamsulosin hydrochloride and processes for preparing the same
12/27/2007WO2007112436A3 Use of polymeric materials with other substances for improved performance
12/27/2007WO2007111720A3 Formulation of insoluble small molecule therapeutics in lipid-based carriers
12/27/2007WO2007106494A3 Methods and compositions for treatment of diastolic heart failure
12/27/2007WO2007099560A3 Method for identification and quantification of polyherbal formulation ingredients
12/27/2007WO2007095162A3 Porous microparticles solid cores
12/27/2007WO2007079389A3 Composition and method of use thereof
12/27/2007WO2007075793A3 Sonication methods for screening and preparing solid forms
12/27/2007WO2007064968A3 Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate
12/27/2007WO2007052289A3 Novel dispersible tablet composition
12/27/2007WO2007024700A8 Exendin for treating diabetes and reducing body weight
12/27/2007WO2007020671A3 Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization
12/27/2007WO2006084139A8 An implantable interferon-containing device
12/27/2007WO2006080951A3 Targeted and high density drug loaded polymeric materials
12/27/2007WO2006064321A3 Controlled release compositions of divalproex sodium
12/27/2007WO2005021009A3 Formulations and methods of treating inflammatory bowel disease
12/27/2007WO2003066824A3 Albumin-fused kunitz domain peptides
12/27/2007US20070299540 Methods of making medical implants of poly (vinyl alcohol) hydrogel
12/27/2007US20070299426 Injectable biocompatible material delivery system
12/27/2007US20070299390 Needleless syringe using supersonic gas flow for particle delivery
12/27/2007US20070299385 Device for the controlled exposure of reservoir-based sensors
12/27/2007US20070299285 Triterpene-Containing Oleogel-Forming Agent, Triterpene-Containing Oleogel and Method for Producing a Triterpene-Containing Oleogel
12/27/2007US20070299240 Biodegradable block copolymers with modifiable surface
12/27/2007US20070299238 Biodegradable block copolymers with modifiable surface
12/27/2007US20070299227 Biodegradable block copolymers with modifiable surface
12/27/2007US20070299141 Novel self-reversible reverse microlatex process for preparing it and cosmetic and industrial uses thereof
12/27/2007US20070299121 administering sublingually to a horse a semisolid transmucosal gel containing detomidine, hydroxypropyl cellulose, sodium lauryl sulfate, propylene glycol and water for providing sedation and analgesia; rapid onset of action, low irritation potential in the oral mucosa
12/27/2007US20070299004 Methods of providing therapeutic effects using cyclosporin compontnts
12/27/2007US20070298461 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
12/27/2007US20070298149 Animal Feedstuff Dyeing and Animal Drugs
12/27/2007US20070298125 Medical Solution, A Method For Producing Said Medical Solution And Use Thereof
12/27/2007US20070298123 Anti-angiogenic compositions and methods of use
12/27/2007US20070298121 Using compositions containing zinc ions, calcium ions, rubidium ions and/or potassium ions; modulates matrix metalloproteinases (MMPs),
12/27/2007US20070298116 Amorphous, spray-dried powders having a reduced moisture content and a high long term stability
12/27/2007US20070298115 Nanoparticulate fibrate formulations
12/27/2007US20070298114 High glass transition temperature absorbable microspheres
12/27/2007US20070298113 Semi-crystalline absorbable microspheres
12/27/2007US20070298112 salt of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester and phosphoric acid; pulmonary disorders
12/27/2007US20070298111 Fine Particle-Containing Composition and Manufacturing Method Therefor
12/27/2007US20070298110 Methods for embedding nanoparticles
12/27/2007US20070298109 Nano-scale devices
12/27/2007US20070298108 Pharmaceutical Formulation
12/27/2007US20070298107 Pharmaceutical Compositions of Mirtazapine
12/27/2007US20070298106 Sustained Release Formulation Containing Selective Serotonin Reuptake Inhibitor and Method for the Preparation Thereof
12/27/2007US20070298105 Methods of treating conditions by sustained release administration of benzimidazole derivatives
12/27/2007US20070298103 Particulates
12/27/2007US20070298102 Extended Release Pharmaceutical Composition of Celecoxib
12/27/2007US20070298101 Controlled-Release Formulation Comprising Tamsulosin Hydrochloride
12/27/2007US20070298100 Compressed Pharmaceutical Compositions Comprising Peg and Electrolytes
12/27/2007US20070298099 Liquid and Semi-Solid Pharmaceutical Formulations for Oral Administration of a Substituted Amide
12/27/2007US20070298098 Controlled Release Compositions Comprising Levetiracetam
12/27/2007US20070298097 Multi-carotenoids compositions and uses therefor
12/27/2007US20070298096 Analgesic/Antipyretic Compositions for Enhanced Absorption
12/27/2007US20070298095 Surface-Modified and Solubility-Improved Hard Capsule
12/27/2007US20070298094 Medicinal Composition, Preparation and Combined Preparation
12/27/2007US20070298093 Synergistic Liposomal Adjuvants
1 ... 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 ... 2991